Aims for Phlebology
Is phlebology a neglected science? Novelties like catheter techniques proceeded much faster in other fields (e.g. cardiology, neuroradiology). Indeed, venous disease is much less dangerous than cardiac infarction or stroke, except rare situations like an embolizing thrombus. However, most of vein diseases COULD be well treated or even prevented, if this was our goal.
The VENARTIS work group believes in a scenario where 80% of epifascial insufficiency can be diagnosed in a reversible stage, for some patients just meaning supervised muscle activation training, for others medical stockings and/or vasoactive drugs, for some minimal focal support by percutaneous valvuloplasty, and for some advanced cases maybe segmental occlusion. If occlusion should be required, just imagine a vein gluing system precise to the millimeter, using truly bioresorbable glue and selling at a price of about 300 USD - wouldn't this mean progress?
Our national and international scientific societies (which we all should support!) will not give their input before products are commercially available and methods have undergone a significant numbers of studies. On the other hand, device manufacturers will flood the market with material on the mere basis of potential earnings.
I would like to close this gap by inviting phlebologists, surgeons, vascular surgeons, dermatologists, angiologists, hematologists and radiologists and all other related scientists and workers, technicians, biologists, biochemists and physicists, to contribute to improvements.
Your advantage of this informal network: You may contribute to progress in a direct and fast way. You will be among the first to know about the pros and cons of all these new developments. You will be among the first to participate in well-designed studies, or to handle new clinical applications. Finally, you will be the first to participate in any economical benefit, if you like to do so. Every idea you share via this website will remain your property (please fill NDA!).
Now, get ready to act!
We are looking forward to your questions and suggestions